跳至主要内容
临床试验/NCT03336086
NCT03336086已完成3 期

Reduction of Natural Killer Cell (CD16/56) and T-lymphocyte (CD3) Subset Counts After a Weight Loss Program Using Anti-obesity Drugs in Obese Women: a Non-randomized Controlled Trial

Shiraz University of Medical Sciences0 个研究点目标入组 29 人开始时间: 2012年3月20日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
29
主要终点
lymphocyte subgroups

研究概览

简要总结

This study included two groups of premenopausal healthy obese women. Experimental group underwent a weight loss program involved a low calorie diet plus anti-obesity drugs and moderate physical activity and control group underwent an ad libitum diet. At baseline and after a 10-15% weight loss lymphocyte subgroups were analyzed and compared between two group.

详细描述

TCD3 and NKC CD16/56 were decreased significantly. Hence this weight loss program impaired viral immunity

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
20 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • BMI >=30
  • no smoking
  • not lactating
  • not pregnant
  • no medication use

排除标准

  • pregnancy
  • any disease
  • any medication use
  • iron and zinc deficiency
  • any supplement use

结局指标

主要结局

lymphocyte subgroups

时间窗: 6 months

TCD3. TCD4. TCD8. BCD19. NKCs CD16/56 (Cells/microliter) by flowcytometry

次要结局

  • Fat Free Mass(6 months)
  • Waist circumference(6 months)
  • Biomarkers(6 months)
  • Systolic blood pressure(6 months)
  • diastolic blood pressure(6 months)
  • Weight(6 months)
  • Fat Mass(6 months)
  • Body Mass Index(6 months)
  • Trunk Fat(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mahsa Mehrdad

Principal investigator

Shiraz University of Medical Sciences

相似试验